We're continuing our renal disorders journey with glomerulonephritis - a group of diseases characterized by immune-mediated inflammation of the glomeruli. I'll guide you through the complex immunological mechanisms, clinical syndromes, and targeted treatment approaches for these conditions. Understanding glomerulonephritis is crucial as it represents a major cause of both acute kidney injury and chronic kidney disease worldwide. Let's explore the intricate world of immune-mediated kidney injury!
🩺 Overview and Classification
Glomerulonephritis encompasses diverse conditions that can be classified by clinical presentation, histopathological findings, or underlying immunological mechanisms.
Clinical Syndromes
- Nephritic syndrome: Hematuria, hypertension, renal impairment
- Nephrotic syndrome: Proteinuria, hypoalbuminemia, edema
- Rapidly progressive GN: Rapid decline in renal function
- Chronic GN: Insidious onset, progressive course
- Asymptomatic urinary abnormalities: Isolated hematuria/proteinuria
Histopathological Patterns
- Focal vs diffuse involvement
- Segmental vs global involvement
- Proliferative vs non-proliferative
- Crescentic vs non-crescentic
- Immune complex deposition patterns
| Type | Key Features | Common Causes | Typical Presentation |
|---|---|---|---|
| Post-infectious GN | Subepithelial humps, C3 deposition | Strep throat, impetigo, endocarditis | Nephritic (children/young adults) |
| IgA Nephropathy | Mesangial IgA deposits | Most common primary GN worldwide | Macroscopic hematuria post-infection |
| Membranous Nephropathy | Subepithelial deposits, thickened GBM | Primary (anti-PLA2R) or secondary | Nephrotic syndrome (adults) |
| MPGN | GBM duplication, C3 dominant | Complement dysregulation, infections | Mixed nephritic/nephrotic |
| ANCA-associated Vasculitis | Pauci-immune, crescentic GN | GPA, MPA, EGPA | RPGN with systemic symptoms |
| Anti-GBM Disease | Linear IgG on GBM | Goodpasture's syndrome | RPGN + pulmonary hemorrhage |
| Lupus Nephritis | Full-house immunofluorescence | Systemic lupus erythematosus | Variable (WHO classes I-VI) |
🔄 Immunopathogenesis
Glomerulonephritis results from various immunological mechanisms that lead to inflammation and damage to the glomerular filtration barrier.
Immune Complex-Mediated
- Antigen-antibody complexes deposit in glomeruli
- Activate complement cascade
- Examples: Post-strep GN, lupus nephritis, MPGN
- Granular deposits on immunofluorescence
- Often associated with hypocomplementemia
Anti-GBM Antibody-Mediated
- Antibodies against type IV collagen (α3 chain)
- Linear IgG deposition along GBM
- Goodpasture's disease/syndrome
- Rapidly progressive course
- Often requires plasmapheresis
ANCA-Associated
- Antibodies against neutrophil cytoplasmic antigens
- Pauci-immune (little immune deposition)
- MPO-ANCA or PR3-ANCA
- Crescentic GN pattern
- Systemic vasculitis manifestations
Complement System in GN
| Complement Abnormality | Associated GN | Mechanism | Treatment Implications |
|---|---|---|---|
| Alternative pathway dysregulation | C3 Glomerulopathy, aHUS | Uncontrolled C3 convertase activity | Complement inhibitors (eculizumab) |
| Classical pathway activation | Immune complex GN, lupus nephritis | Immune complex deposition | Immunosuppression, complement monitoring |
| Lectin pathway activation | Some infection-related GN | Mannose-binding lectin activation | Treat underlying infection |
👨⚕️ Clinical Presentation
GN presentations range from asymptomatic urinary abnormalities to rapidly progressive renal failure. Recognizing clinical syndromes guides initial evaluation and urgency of intervention.
Classic Clinical Syndromes
Nephritic Syndrome
- Hematuria (often macroscopic)
- Hypertension
- Oliguria, elevated creatinine
- Edema (mild to moderate)
- RBC casts on urinalysis
- Examples: Post-strep GN, IgA nephropathy
Nephrotic Syndrome
- Heavy proteinuria (>3.5 g/day)
- Hypoalbuminemia (<3.0 g/dL)
- Edema (often severe)
- Hyperlipidemia
- Lipiduria (oval fat bodies)
- Examples: Membranous nephropathy, MCD
Rapidly Progressive GN (RPGN)
| Feature | Description | Urgent Actions | Common Causes |
|---|---|---|---|
| Clinical Presentation | Rapid decline in renal function (days-weeks) | Immediate nephrology referral | ANCA vasculitis, anti-GBM, severe lupus |
| Histological Hallmark | Crescentic GN (>50% glomeruli with crescents) | Urgent kidney biopsy | All RPGN causes show crescents |
| Systemic Manifestations | Often present (fever, weight loss, rash) | Comprehensive systemic evaluation | Vasculitides, SLE, infections |
| Treatment Urgency | Renal survival time-sensitive | Immediate immunosuppression | All require aggressive treatment |
🔍 Diagnostic Approach
GN diagnosis requires a systematic approach including urinalysis, serological testing, and often kidney biopsy for definitive diagnosis and prognosis.
Diagnostic Workup
| Test Category | Key Tests | Interpretation | Clinical Utility |
|---|---|---|---|
| Urinalysis | Dipstick, microscopy, protein quantification | RBC casts (nephritic), lipiduria (nephrotic) | Differentiate nephritic vs nephrotic |
| Renal Function | Creatinine, eGFR, albumin, lipids | Degree of impairment, nephrotic criteria | Assess severity, monitor progression |
| Serological Tests | ANA, ANCA, anti-GBM, complements, ASO | Pattern suggests specific diseases | Guide diagnosis before biopsy |
| Infection Workup | Hepatitis B/C, HIV, blood cultures | Identify secondary causes | Essential before immunosuppression |
| Kidney Biopsy | Light microscopy, IF, EM | Definitive diagnosis, activity/chronicity | Gold standard, guides treatment |
Serological Patterns in Common GN
Low Complement Diseases
- Lupus nephritis: Low C3, C4
- Post-infectious GN: Low C3, normal C4
- MPGN: Low C3, variable C4
- Cryoglobulinemia: Low C4, normal C3
- Bacterial endocarditis: Low C3, normal C4
Normal Complement Diseases
- IgA nephropathy: Normal complements
- ANCA vasculitis: Normal complements
- Anti-GBM disease: Normal complements
- Membranous nephropathy: Normal complements
- Minimal change disease: Normal complements
💊 Management Strategies
GN management involves immunosuppressive therapy tailored to the specific disease, severity, and histological findings, plus supportive care for complications.
Immunosuppressive Therapies
| Disease | Induction Therapy | Maintenance Therapy | Special Considerations |
|---|---|---|---|
| Lupus Nephritis (Class III/IV) | Mycophenolate mofetil or Cyclophosphamide + steroids | Mycophenolate or Azathioprine | Hydroxychloroquine background therapy |
| ANCA Vasculitis | Rituximab or Cyclophosphamide + steroids | Azathioprine or Rituximab | Plasma exchange for severe renal involvement |
| Anti-GBM Disease | Plasma exchange + Cyclophosphamide + steroids | None (usually self-limited) | Treatment delay worsens prognosis significantly |
| Membranous Nephropathy | Conservative (if low risk) or Rituximab/cyclosporine | Same as induction if response | Check anti-PLA2R antibodies for monitoring |
| IgA Nephropathy | RAAS blockade, corticosteroids if high risk | RAAS blockade, fish oil, SGLT2 inhibitors | Target proteinuria <1 g/day, BP <130/80 |
Supportive Care
General Measures
- Blood pressure control (target <130/80)
- RAAS blockade (ACEi/ARB) for proteinuria
- Salt restriction (<2 g/day)
- Protein restriction (0.8 g/kg if CKD)
- Smoking cessation
Complication Management
- Edema: Diuretics, fluid restriction
- Hyperlipidemia: Statins
- Thromboembolism: Prophylactic anticoagulation if high risk
- Infections: Vaccinations, PJP prophylaxis if immunosuppressed
- Bone health: Calcium/vitamin D, monitor for osteopenia
⚠️ Special Considerations
Certain GN scenarios require specific diagnostic and therapeutic approaches due to unique pathophysiology or clinical contexts.
Pregnancy and GN
- GN may flare during pregnancy
- Some immunosuppressives contraindicated
- Increased pre-eclampsia risk
- Fetal monitoring essential
- Multidisciplinary care required
GN in Elderly
- ANCA vasculitis more common
- Increased infection risk with immunosuppression
- Comorbidities complicate management
- Individualized risk-benefit assessment
- Consider reduced intensity regimens
🌱 Prognosis and Monitoring
GN outcomes vary widely based on type, severity, and treatment response. Long-term monitoring is essential for detecting relapses and managing complications.
Prognostic Factors
- Degree of proteinuria at presentation
- Renal function at diagnosis
- Histological findings (crescents, scarring)
- Treatment response
- BP control during follow-up
Monitoring Parameters
- Serial creatinine and eGFR
- Proteinuria quantification
- BP measurements
- Serological markers (ANCA, anti-dsDNA, etc.)
- Medication side effects
Long-term Complications
- Progression to CKD/ESRD
- Cardiovascular disease
- Infections (immunosuppression-related)
- Malignancy (prolonged immunosuppression)
- Treatment-related toxicities
🧠 Key Takeaways
- GN encompasses diverse immune-mediated kidney diseases
- Classified as nephritic, nephrotic, or rapidly progressive syndromes
- Pathogenesis involves immune complex, anti-GBM, or ANCA mechanisms
- Diagnosis requires urinalysis, serology, and often kidney biopsy
- Treatment involves immunosuppression tailored to specific disease
- Supportive care includes BP control and RAAS blockade
- Prognosis varies widely based on type and severity
- Long-term monitoring is essential for detecting relapses
🧭 Conclusion
We've explored the complex world of glomerulonephritis, student—from the intricate immunological mechanisms to the nuanced treatment approaches for different disease entities. Remember that GN represents a paradigm of immune-mediated organ damage where precise diagnosis guides targeted therapy. I encourage you to master the clinical syndromes and serological patterns that point to specific diagnoses, as this knowledge can dramatically impact patient outcomes. Excellent work building your nephrology knowledge! Next, we'll examine nephrotic syndrome and its diverse causes and management strategies.
In glomerulonephritis management, the kidney biopsy is not just a diagnostic tool but a prognostic guide and treatment roadmap.